Many patients take bisphosphonate drugs for osteoporosis. Are they at risk for developing jaw osteonecrosis (ONJ)? The pathogenesis of ONJ, its clinical features and treatment strategies will be discussed, as well as issues of informed consent.

Learning Outcomes:
1. Understand ONJ risk factors
2. Know the signs and symptoms of ONJ
3. Learn how to prevent and treat ONJ

This course is brought to you by OralLongevity, an initiative between GlaxoSmithKline and the ADA, and presented in cooperation with the Special Care Dentistry Association.